低分子量富可伊丹:生产方法及其治疗应用
Rasika Gunarathne1, Chunyang Zhang2, Jinrong Zhou3
1Auckland Bioengineering Institute, the University of Auckland, Auckland 1142, New Zealand.
International journal of biological macromolecules
|June 18, 2025
概括
低分子量富可伊丹 (LMWF) 显示出用于治疗的增强生物活性. 酶去聚合提供受控的减少,保持fucoidan的保存.
科学领域:
- 海洋天然产品 海洋天然产品
- 生物技术是生物技术.
- 药理学 药理学是指药理学的学科.
背景情况:
- 富科伊丹是一种来自棕藻的硫酸多糖,具有多样化的生物活性.
- 高分子量福科丹的治疗潜力受到其大小的限制.
- 低分子量富可伊丹 (LMWF) 显示出卓越的生物活性和生物可用性.
研究的目的:
- 审查目前的富可伊丹脱聚合策略.
- 讨论LMWF的治疗应用.
- 突出脱聚合方法对LMWF特性和有效性的影响.
主要方法:
- 关于富可伊丹脱聚合技术的科学文献的综述.
- 分析各种降解方法:酶,光催化,基,酸水解,超声波辅助,过氧化介导和水热.
- 检查LMWF的结构-活动关系.
主要成果:
- 酶降解是控制LMWF生产的首选方法,可以保持结构完整性.
- LMWF表现出显著的抗炎,抗氧化,抗糖尿病,抗癌,低脂,抗肥胖,肝脏保护和脏保护作用.
- 分子重量,硫化度,单糖组成和尿酸含量极大地影响LMWF的生物活性.
结论:
- 由于其强大的生物活性,LMWF对营养药和制药应用具有重大前景.
- 优化脱聚合技术对于最大限度地提高LMWF治疗疗效至关重要.
- 进一步研究先进的脱聚合策略和LMWF的全面治疗评估是有必要的.
更多相关视频
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
278
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
278
Drugs for Treatment of Ulcerative Colitis in IBD
244
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
244


